Latest Breaking News On - புற்றுநோய் கண்டுபிடிப்பு - Page 3 : comparemela.com
Combination of Experimental Drug Classes Shown to Extend Survival in Mice with Lung Cancer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
p53 Unleashes Endogenous Retroviruses to Tackle Tumors: Study
the-scientist.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from the-scientist.com Daily Mail and Mail on Sunday newspapers.
Many Pandemic-Driven Changes to Cancer CTs Should Remain
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Representative Image | Pic: Express
A team of researchers has developed a novel therapy that could be effective for different types of cancers. The study, published in the journal Cancer Discovery, indicates that the therapeutic agent shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive. Translating these findings into effective cancer therapies for patients is a high priority, said researcher Jian Jin from Mount Sinai in the US. According to the researchers, the therapy is an engineered molecule, MS21, that causes the degradation of AKT, an enzyme that is overly active in many cancers.
This study laid out evidence that pharmacological degradation of AKT is a viable treatment for cancers with mutations in certain genes, the researchers said.
Novel therapy might be effective in many cancers
By IANS |
0 Views
High-Fibre Diet May Lower Colon Cancer Risk. Image Source: IANS News
New York, July 25 : A team of researchers has developed a novel therapy that could be effective for different types of cancers.
The study, published in the journal Cancer Discovery, indicates that the therapeutic agent shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive. Translating these findings into effective cancer therapies for patients is a high priority., said researcher Jian Jin from Mount Sinai in the US.
According to the researchers, the therapy is an engineered molecule, MS21, that causes the degradation of AKT, an enzyme that is overly active in many cancers.